Differences in hepatitis A seroprevalence among geographical regions in Turkey: A need for regional vaccination recommendations

Journal of Viral Hepatitis

Volumn 15, Issue SUPPL.2, 2008, Pages 69-72

  Ceyhan, M ^a   Yildirim, I ^a   Kurt, N ^b   Uysal, G ^c   Dikici, B ^d   Ecevit, C ^e   Aydogan, A ^e   Koc, A ^f   Yasa, O ^g   Koseoglu M ^h   Onal, K ^h   Hacimustafaoglu, M ⁱ   Celebi, S ⁱ  

^a HACETTEPE UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c Diskapi Yildirim Beyazit Education and Training Hospital   (Turkey)

^d DUZCE UNIVERSITY   (Turkey)

^e DR BEHÇET UZ CHILDREN'S HOSPITAL   (Turkey)

^f HARRAN UNIVERSITY   (Turkey)

^g Goztepe Hospital   (Turkey)

^h Ataturk State Hospital   (Turkey)

ⁱ ULUDAG UNIVERSITY   (Turkey)

Author keywords

Endemicity; Geographical variation; Hepatitis A virus; Seroprevalence; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; CHILD; CONFERENCE PAPER; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CENTER; HEPATITIS A; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SEROPREVALENCE; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GEOGRAPHY; HEALTH PLANNING GUIDELINES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TURKEY; VACCINATION;

EID: 50649125466     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01034.x     Document Type: Conference Paper

References (24)

1. Bell BP. Global epidemiology of hepatitis A:implications for control stragegies. In : Margolis HS, Alter MJ, Liang J, Dienstag J, eds. Viral Hepatitis and Liver Disease. London : International Medical Press, 2002 : 9 14.
2. Koff RS. Clinical manifestations and diagnosis of hepatitis A virus infection. Vaccine 1992 10 (Suppl. 1 S15 S17.
3. Gust ID. Epidemiological patterns of hepatitis A in different parts of the world. Vaccine 1992 10 (Suppl. 1 S56 S58.
4. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005 34 (3 600 609.
5. Howitz M, Mazick A, Molbak K. Hepatitis A outbreak in a group of Danish tourists returning from Turkey. Euro Surveill 2005 10 : E051201.
6. Hutin YJ, Pool V, Cramer EH et al. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N Engl J Med 1999 340 (8 595 602.
7. Wheeler C, Vogt TM, Armstrong GL et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005 353 (9 890 897.
8. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005 294 (2 202 210.
9. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the Era of Vaccination. JAMA 2005 294 : 194 201.
10. Dominguez A, Bruguera M, Plans P, Costa J, Salleras L. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. J Med Virol 2004 73 (2 172 176.
11. Bell BP, Feinstone SM. Hepatitis A vaccine. In : Plotkin S, Orenstein W, eds. Vaccines. Philadelphia : Saunders, 2004 : 269 298.
12. Beutels M, Van Damme P, Vranckx R, Meheus A. The shift in prevalence of hepatitis A immunity in Flanders, Belgium. Acta Gastroenterol Belg 1998 61 (1 4 7.
13. Cilla G, Perez-Trallero E, Artieda J, Serrano-Bengoechea E, Montes M, Vicente D. Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004. Epidemiol Infect 2007 135 (3 402 408.
14. Das K, Jain A, Gupta S et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol 2000 16 (6 507 510.
15. Kiyohara T, Sato T, Totsuka A, Miyamura T, Ito T, Yoneyama T. Shifting seroepidemiology of hepatitis A in Japan, 1973-2003. Microbiol Immunol 2007 51 (2 185 191.
16. Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol 1997 13 (4 417 420.
17. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine 2000 18 (Suppl. 1 S61 S64.
18. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000 18 (Suppl. 1 S68 S70.
19. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000 18 (Suppl. 1 S65 S67.
20. World Health Organization. Hepatitis A vaccines: WHO position paper. Wkly Epidemiol Rec 2000 75 : 38 44.
21. Kanra G, Tezcan S, Badur S. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002 44 (3 204 210.
22. Yapicioglu H, Alhan E, Yildizdas D, Yaman A, Bozdemir N. Prevalence of hepatitis A in children and adolescents in Adana, Turkey. Indian Pediatr 2002 39 (10 936 941.
23. Geyman A, Baz I. Monitoring urban growth and detecting land cover changes on the Istanbul metropolitan area. Environ Monit Assess 2008 136 : 449 459.
24. Sonder GJ, Bovée LP, Baayen TD, Coutinho RA, van den Hoek JA. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004). Vaccine 2006 24 : 4962 4968.